Table 1.
Subject’s characteristics
| Con (n=7) | AAA before EVAR (n=7) | AAA after EVAR (n=7) | p | |
|---|---|---|---|---|
| Age, years | 69±9.81 | 67±9.41 | 67±9.41 | N.S |
| Male sex, N (%) | 4 (57%) | 5 (71%) | 5 (71%) | N.S |
| SBP, mmHg | 132.14±10.62 | 130.57±10.09 | 130.14±6.33 | N.S |
| DBP, mmHg | 73.57±6.26 | 70±6.95 | 71±10.18 | N.S |
| Hypertension (%) | 5 (71%) | 6 (86%) | 6 (86%) | N.S |
| Diabetes (%) | 1 (14%) | 1 (14%) | 1 (14%) | N.S |
| Smoking (%) | 4 (57%) | 4 (57%) | 4 (57%) | N.S |
| CAD（%） | 2 (29%) | 1 (14%) | 1 (14%) | N.S |
| Diameter (mm) | 18.28±2.56 | 58.09±11.24* | 23.14±1.07# | <0.05 |
| WBC (109/l) | 7.10±1.10 | 6.68±1.41 | 6.52±1.36 | N.S |
| Platelet (109/l) | 205.71±48.33 | 214±49.06 | 257.86±89.75 | N.S |
| Creatinine, μmol/l | 71.56±21.93 | 73.5±13.32 | 71.69±7.73 | N.S |
| Hemoglobin, mmol/l | 31.01±1.15 | 30.03±1.85 | 29.24±1.97# | <0.05 |
| Total cholesterol, mmol/l | 4.89±1.26 | 4.43±0.65* | 3.93±0.99* | <0.05 |
| Triglyceride, mmol/l | 2.18±0.93 | 1.23±0.28 | 1.1±0.36 | N.S |
Demographic and clinical characteristics, comorbodity conditions, complications of all subjects. Data are displayed as means±SD or number (%). AAA: abdominal aortic aneurysm, EVAR: endovascular aneurysm repair, DBP: diastolic blood pressure, SBP: systolic blood pressure, CAD: coronary artery disease, WBC: white blood cell. *p<0.05 compared to Con. #p<0.05 compared to AAA before EVAR.